Developing dendritic cell for sars-cov-2 vaccine: breakthrough in the pandemic

HIGHLIGHTS

  • who: Terawan Agus Jonny Jonny from the National Cancer Institute (NIH), United States University Medical Center Regensburg have published the research work: Developing dendritic cell for SARS-CoV-2 vaccine: Breakthrough in the pandemic, in the Journal: (JOURNAL)
  • how: This article discuss the potential development of DC as a SARS-CoV-2 vaccine by focusing on the role of T_cells and DC in SARSCoV-2 infection the formation of immunity in SARS-CoV-2 infection and the role of DC in shaping immunity which is the foundation for the development of DC as a SARS . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?